SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-007817
Filing Date
2016-08-09
Accepted
2016-08-09 16:31:18
Documents
53
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bpmc-20160630x10q.htm 10-Q 1616242
2 EX-10.1 bpmc-20160630ex10190ad0c.htm EX-10.1 29653
3 EX-31.1 bpmc-20160630ex311135b37.htm EX-31.1 18120
4 EX-31.2 bpmc-20160630ex3121e0670.htm EX-31.2 18300
5 EX-32.1 bpmc-20160630ex32111e8fd.htm EX-32.1 14333
  Complete submission text file 0001558370-16-007817.txt   5263397

Data Files

Seq Description Document Type Size
6 EX-101.INS bpmc-20160630.xml EX-101.INS 921473
7 EX-101.SCH bpmc-20160630.xsd EX-101.SCH 41389
8 EX-101.CAL bpmc-20160630_cal.xml EX-101.CAL 43453
9 EX-101.DEF bpmc-20160630_def.xml EX-101.DEF 155404
10 EX-101.LAB bpmc-20160630_lab.xml EX-101.LAB 419622
11 EX-101.PRE bpmc-20160630_pre.xml EX-101.PRE 278124
Mailing Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37359 | Film No.: 161818388
SIC: 2834 Pharmaceutical Preparations